The risk of malignant hyperthermia in neuromyotonia is low
Revista Española de Anestesiología y Reanimación (English Edition) · 2024
DOI: 10.1016/j.redare.2024.02.005 ↗Kurz gefasst
Leserbrief in der Zeitschrift Revista Española de Anestesiología y Reanimación (English Edition), 2024. Verfasst von J Finsterer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Neurology & Neurophysiology Center, Vienna, Austria. Electronic address: fifigs1@yahoo.de. Hauptthemen laut MEDLINE: Malignant Hyperthermia, Isaacs Syndrome. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Neurology & Neurophysiology Center, Vienna, Austria. Electronic address: fifigs1@yahoo.de.
- Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil.
- Centro de Neurociências e Saúde da Mulher "Professor Geraldo Rodrigues de Lima", Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.
Zitieren
APA
Finsterer, J., Scorza, F. A., & de Almeida, A. G. (2024). The risk of malignant hyperthermia in neuromyotonia is low. Revista Española de Anestesiología y Reanimación (English Edition). https://doi.org/10.1016/j.redare.2024.02.005
Vancouver
Finsterer J, Scorza FA, de Almeida AG. The risk of malignant hyperthermia in neuromyotonia is low. Revista Española de Anestesiología y Reanimación (English Edition). 2024. doi:10.1016/j.redare.2024.02.005
BibTeX
@article{Finsterer2024,
author = {Finsterer, J and Scorza, F A and de Almeida, A-C G},
title = {The risk of malignant hyperthermia in neuromyotonia is low},
journal = {Revista Española de Anestesiología y Reanimación (English Edition)},
year = {2024},
doi = {10.1016/j.redare.2024.02.005}
}
EUVIMED